Tharimmune

Biotechnology company(THAR)

Sobre Tharimmune

Tharimmune, Inc. (THAR) is a clinical-stage biotechnology company developing a portfolio of therapeutic candidates for inflammation and immunology.

Comunidade
Website
Etiquetas
Digital Asset Treasury
Publicly listed company
Crypto Stocks

Tendência de mudança de índice em alta

Investidores

Liberty City Ventures
Liberty City Ventures
DRW Venture Capital
DRW Venture Capital
Kraken
Kraken
Polychain
Polychain
ARK Invest
ARK Invest

Detalhes da arrecadação de fundos

Post-IPO(2025-11-03)
QuantiaR$2,82B
Investidores
Liberty City Ventures
Liberty City Ventures
DRW Venture Capital
DRW Venture Capital
Kraken
Kraken
Polychain
Polychain
ARK Invest
ARK Invest
Valorização--